nach oben

Erschienen in:

01.01.2008

Different Gene Expression Patterns in the Bone Tissue of Aging Postmenopausal Osteoporotic and Non-osteoporotic Women

verfasst von: Bernadett Balla, János P. Kósa, János Kiss, Adrienn Borsy, János Podani, István Takács, Áron Lazáry, Zsolt Nagy, Krisztián Bácsi, Gábor Speer, László Orosz, Péter Lakatos

Erschienen in: Calcified Tissue International | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify genes that are differently expressed in osteoporotic and non-osteoporotic human bone and to describe the relationships between these genes using multivariate data analysis.

Methods

Seven bone tissue samples from postmenopausal osteoporotic patients and 10 bone tissue samples from postmenopausal non-osteoporotic women were examined in our study. Messenger RNA was prepared from each sample and reverse transcribed to cDNA. The expression differences of 87 selected genes were analyzed in a Taqman probe-based quantitative real-time RT-PCR system.

Results

A Mann-Whitney U-test indicated significant differences in the expression of nine genes (p ≤ 0.05). Seven of these nine genes–ALPL, COL1A1, MMP2, MMP13, MMP9, PDGFA, NFKB1—were significantly downregulated in the bone tissue of osteoporotic women, while CD36 and TWIST2 were significantly upregulated in osteoporotic patients. Principal components analysis was used to evaluate data structure and the relationship between osteoporotic and non-osteoporotic phenotypes based on the multiple mRNA expression profiles of 78 genes. Canonical variates analysis demonstrated further that osteoporotic and non-osteoporotic tissues can be distinguished by expression analysis of genes coding growth factors/non-collagen matrix molecules, and genes belonging to the canonical TGFB pathway.

Conclusion

Significant differences observed in gene expression profiles of osteoporotic and non-osteoporotic human bone tissues provide further insight into the pathogenesis of this disease. Characterization of the differences between osteoporotic and non-osteoporotic bones by expression profiling will contribute to the development of diagnostic tools in the future.

Prentice A (2001) The relative contribution of diet and genotype to bone development. Proc Nutr Soc 60:45–52PubMedCrossRef

Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–11PubMedCrossRef

Ralston SH (2005) Genetic determinants of osteoporosis. Curr Opin Rheumatol 17:475–479PubMedCrossRef

Zajickova K, Zofkova I (2003) Osteoporosis: Genetic analysis of multifactorial disease. Endocr Regul 37:31–44PubMed

Rizzoli R, Bonjour JP, Ferrari SL (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26:79–94PubMedCrossRef

Dvornyk V, Recker RR, Deng HW (2003) Gene expression studies of osteoporosis: Implications for microarray research. Osteoporos Int 14:451–461PubMedCrossRef

Ralston SH (1994) Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9:883–890PubMedCrossRef

Abrahamsen B, Shalhoub V, Larson EK, Eriksen EF, Beck-Nielsen H, Marks SC Jr (2000) Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women. Bone 26:137–145PubMedCrossRef

Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRef

10.

Jolliffe I (1986) Principal component analysis. Springer, Berlin Heidelberg New York

11.

Podani J (2000) Introduction to the exploration of multivariate biological data. Backhuys, Leiden

12.

Raychaudhuri S, Stuart JM, Altman RB (2000) Principal components analysis to summarize microarray experiments: Application to sporulation time series. Pac Symp Biocomput [2000]:455–466

13.

Yeung KY, Ruzzo WL (2001) Principal component analysis for clustering gene expression data. Bioinformatics 17:763–774PubMedCrossRef

14.

Dai JJ, Lieu L, Rocke D (2006) Dimension reduction for classification with gene expression microarray data. Stat Appl Genet Mol Biol 5:article 6

15.

Cattell R (1966) The scree test for the number of factors. Multivar Behav Res 1:140–161

16.

Podani J (2001) SYN-TAX 2000: User’s manual. Scientia, Budapest

17.

Kawabata M, Imamura T, Miyazono K (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9:49–61PubMedCrossRef

18.

Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51–65PubMedCrossRef

19.

Turner RT, Riggs BL, Spelsberg TC (1994) Skeletal effects of estrogen. Endocr Rev 15:275–300PubMedCrossRef

20.

Manolagas SC, Kousteni S, Jilka RL (2002) Sex steroids and bone. Recent Prog Horm Res 57:385–409PubMedCrossRef

21.

Christenson RH (1997) Biochemical markers of bone metabolism: An overview. Clin Biochem 30:573–593PubMedCrossRef

22.

Vega D, Maalouf NM, Sakhaee K (2007) The role of RANK/RANKL/OPG: Clinical implications. J Clin Endocrinol Metab 92(12):4514–4521PubMedCrossRef

23.

Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221–233PubMedCrossRef

24.

Torricelli P, Fini M, Giavaresi G, Giardino R (2002) Human osteoblast cultures from osteoporotic and healthy bone: Biochemical markers and cytokine expression in basal conditions and in response to 1,25(OH)2D₃. Artif Cells Blood Substit Immobil Biotechnol 30:219–227PubMedCrossRef

25.

Mueller SM, Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82:583–590PubMedCrossRef

26.

Rodriguez JP, Montecinos L, Rios S, Reyes P, Martinez J (2000) Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 79:557–565PubMedCrossRef

27.

Abdallah BM, Haack-Sorensen M, Fink T, Kassem M (2006) Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39:181–188PubMedCrossRef

28.

Cao J, Venton L, Sakata T, Halloran BP (2003) Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 18:270–277PubMedCrossRef

29.

Carron JA, Wagstaff SC, Gallagher JA, Bowler WB (2000) A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro. Biochem Biophys Res Commun 270:1124–1127PubMedCrossRef

30.

Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA (1998) Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39:777–788PubMed

31.

Kawaguchi H, Akune T, Yamaguchi M, Ohba S, Ogata N, Chung UI, Kubota N, Terauchi Y, Kadowaki T, Nakamura K (2005) Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells. J Bone Miner Metab 23:275–279PubMedCrossRef

32.

Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B (2004) Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3:379–389PubMedCrossRef

33.

Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21:76–83PubMedCrossRef

34.

Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229–240PubMedCrossRef

35.

Tamura M, Noda M (1999) Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. J Cell Biochem 72:167–176PubMedCrossRef

36.

Gong XQ, Li L (2002) Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. J Biol Chem 277:12310–12317PubMedCrossRef

37.

Lee MS, Lowe G, Flanagan S, Kuchler K, Glackin CA (2000) Human Dermo-1 has attributes similar to twist in early bone development. Bone 27:591–602PubMedCrossRef

38.

Schroeder TM, Westendorf JJ (2005) Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res 20:2254–2263PubMedCrossRef

39.

Leeman MF, Curran S, Murray GI (2002) The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 37:149–166PubMedCrossRef

40.

Fridman R, Toth M, Pena D, Mobashery S (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548–2555PubMed

41.

Knauper V, Smith B, Lopez-Otin C, Murphy G (1997) Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem/FEBS 248:369–373CrossRef

42.

Hatori K, Sasano Y, Takahashi I, Kamakura S, Kagayama M, Sasaki K (2004) Osteoblasts and osteocytes express MMP2 and -8 and TIMP1, -2, and -3 along with extracellular matrix molecules during appositional bone formation. Anat Rec A 277:262–271CrossRef

43.

Filanti C, Dickson GR, Di Martino D, Ulivi V, Sanguineti C, Romano P, Palermo C, Manduca P (2000) The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res 15:2154–2168PubMedCrossRef

44.

Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879–889PubMedCrossRef

45.

Rydziel S, Shaikh S, Canalis E (1994) Platelet-derived growth factor-AA and -BB (PDGF-AA and -BB) enhance the synthesis of PDGF-AA in bone cell cultures. Endocrinology 134:2541–2546PubMedCrossRef

46.

Hock JM, Canalis E (1994) Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 134:1423–1428PubMedCrossRef

47.

Fiedler J, Etzel N, Brenner RE (2004) To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990–998PubMedCrossRef

48.

Tanaka H, Wakisaka A, Ogasa H, Kawai S, Liang CT (2002) Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats. J Endocrinol 174:63–70PubMedCrossRef

49.

Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17–25PubMedCrossRef

50.

Park H, Jung YK, Park OJ, Lee YJ, Choi JY, Choi Y (2005) Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol 175:7193–201PubMed

51.

Ozeki N, Mogi M, Nakamura H, Togari A (2002) Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells. Arch Oral Biol 47:511–517PubMedCrossRef

52.

Atkins GJ, Bouralexis S, Evdokiou A, Hay S, Labrinidis A, Zannettino AC, Haynes DR, Findlay DM (2002) Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone 31:448–56PubMedCrossRef

53.

Roux S, Lambert-Comeau P, Saint-Pierre C, Lepine M, Sawan B, Parent JL (2005) Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochem Biophys Res Commun 333:42–50PubMedCrossRef

Titel: Different Gene Expression Patterns in the Bone Tissue of Aging Postmenopausal Osteoporotic and Non-osteoporotic Women
verfasst von: Bernadett Balla
János P. Kósa
János Kiss
Adrienn Borsy
János Podani
István Takács
Áron Lazáry
Zsolt Nagy
Krisztián Bácsi
Gábor Speer
László Orosz
Péter Lakatos
Publikationsdatum: 01.01.2008
Verlag: Springer-Verlag
Erschienen in: Calcified Tissue International / Ausgabe 1/2008
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-007-9092-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Different Gene Expression Patterns in the Bone Tissue of Aging Postmenopausal Osteoporotic and Non-osteoporotic Women